Expiring federal contract
75N98026P01001 — Life Technologies Corporation
Department of Health and Human Services · National Institutes of Health
- Contract / PIID
- 75N98026P01001
- Incumbent
- Life Technologies Corporation
- Incumbent UEI
- EB8QTC6575E7
- Current end date
- August 6, 2027
- Potential total value
- $109,676
- Obligated
- $109,676
- NAICS
- 325414 — Biological Product (except Diagnostic) Manufacturing
- PSC
- 6640 — LABORATORY EQUIPMENT AND SUPPLIES
- Set-aside
- Not stated
- Start date
- August 7, 2026
- Place of performance
- CA
- Award type
- PURCHASE ORDER
Source: USASpending.gov award record, last checked November 18, 2026. Place of performance as reported by USASpending.
What the contract covers
XOME ENRICHMENT AND SEQUENCING REGENTS ARE REQUIRED FOR WHOLE-EXOME SEQUENCING TO IDENTIFY UNCOMMON AND RARE SEQUENCE VARIANTS ACROSS ALL PROTEIN CODING SEQUENCES THAT CONTRIBUTE TO ALCOHOL-RELATED PHENOTYPES IN NEWLY RECRUITED PATIENTS WITH ALCOHOL
Likely rebid window (estimate)
- Sources Sought / RFI: about Aug 2026 – Feb 2027 (6–12 months before the end date)
- RFP: about Apr 2027 – Jun 2027 (2–4 months before the end date)
Now inside the estimated Sources Sought / RFI window.
Estimated from the current end date using typical federal recompete timing. Agencies set their own schedules, and contracts are often extended. This is not a published solicitation date.
Track this recompete free
- Change history: no changes recorded since Mindy began tracking this contract.
- Alerts: get an email when the end date moves or the follow-on is posted.
- Contacts: the buying office and small-business contacts for this agency.
Other contracts expiring at Department of Health and Human Services (NAICS 325414)
- 75A50125C00002 — Sanofi Vaccines US INC. · ends January 31, 2027 · $53M
- 75A50124F61004 — Advanced Technology International · ends April 11, 2027 · $51M
- 75A50126F61013 — Seqirus INC · ends May 8, 2027 · $450K
- 75N93023P00594 — Dna Twopointo INC. · ends May 13, 2027 · $300K
- 75N98026P00545 — Somalogic Operating CO., INC · ends May 14, 2027 · $522K
- 75A50124F61008 — Seqirus INC · ends May 21, 2027 · $23M
- 75A50124F61009 — Seqirus INC · ends May 21, 2027 · $396K
- 75N98026P00626 — Olink Proteomics INC · ends May 28, 2027 · $207K
- 75N98026P00928 — Pacific Biosciences Of California, INC · ends July 7, 2027 · $347K
- 75N98026F00001 — Roche Diagnostics Corporation · ends August 31, 2027 · $127K